An MRI measure of degenerative and cerebrovascular pathology in Alzheimer disease.

ABSTRACT:

Objective

To develop, replicate, and validate an MRI-based quantitative measure of both cerebrovascular and neurodegeneration in Alzheimer disease (AD) for clinical and potentially research purposes.

Methods

We used data from a cross-sectional and longitudinal community-based study of Medicare-eligible residents in northern Manhattan followed every 18-24 months (n = 1,175, mean age 78 years). White matter hyperintensities, infarcts, hippocampal volumes, and cortical thicknesses were quantified from MRI and combined to generate an MRI measure associated with episodic memory. The combined MRI measure was replicated and validated using autopsy data, clinical diagnoses, and CSF biomarkers and amyloid PET from the Alzheimer's Disease Neuroimaging Initiative.

Results

The qu

SUBMITTER: Brickman AM 

PROVIDER: S-EPMC6177275 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature